Mesenchymal Cell News Volume 15.03 | Jan 24 2023

    0
    22








    2023-01-24 | MSCN 15.03


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 15.03 – 24 January, 2023
    TOP STORY

    Lymphatic Vessels in Bone Support Regeneration after Injury

    The authors found that lymphatic vessels in bone expanded during genotoxic stress. VEGF-C/VEGFR-3 signaling and genotoxic stress-induced IL6 drove lymphangiogenesis in bones.
    [Cell]

    Full ArticleGraphical AbstractPress Release

    Scientific resources to support your stem cell research. Learn More!
    PUBLICATIONSRanked by the impact factor of the journal

    Sensory Nerve Niche Regulates Mesenchymal Stem Cell Homeostasis via FGF/mTOR/Autophagy Axis

    Investigators showed that the sensory nerve was vital for mesenchymal tissue homeostasis and maintenance of MSCs in the continuously growing adult mouse incisor. Loss of sensory innervation led to mesenchymal disorder and a decrease in MSCs.
    [Nature Communications]

    Full Article

    Vessel-Derived Decellularized Extracellular Matrices (VdECM): Novel Bio-Engineered Materials for the Wound Healing

    Blood vessel-derived extracellular matrix (VdECM) in hydrogel form was microscopically examined, tested for fibroblast proliferation, and examined for L/D staining. Cytokine array of various growth factors in adipocyte-derived mesenchymal stem cell media with VdECM was done.
    [Tissue Engineering And Regenerative Medicine]

    Abstract

    Regulatory Role of Apelin Receptor Signaling in Migration and Differentiation of Mouse Embryonic Stem Cell-Derived Mesoderm Cells and Mesenchymal Stem/Stromal Cells

    The authors elucidated the role of apelin receptor signaling during mesoderm cell migration and differentiation from mouse embryonic stem cells.
    [Human Cell]

    Abstract

    Characterization of Mesenchymal Stem Cells in Pre-B Acute Lymphoblastic Leukemia

    Scientists investigated the cellular and transcriptome profiles of MSCs isolated from the bone marrow microenvironment of an immunocompetent BCR-ABL1+ model of B cell acute lymphoblastic leukemia.
    [Frontiers In Cell And Developmental Biology]

    Full Article

    Mechanosensitive miR-99b Mediates the Regulatory Effect of Matrix Stiffness on Bone Marrow Mesenchymal Stem Cell Fate Both In Vitro and In Vivo

    Researchers found that the expression of miR-99b increased with increasing hydrogel stiffness and that miR-99b regulated the proliferation and differentiation of BMSCs seeded on the surface of substrates with different stiffnesses.
    [APL Bioengineering]

    Full Article

    Overexpression of NT3P75-2 Gene Modified Bone Marrow Mesenchymal Stem Cells Supernatant Promotes Neurological Function Recovery in ICH Rats

    Scientists evaluated changes in microglia activation, neuron survival and proliferation of neural stem cells. Compared with the GFP group and the GFP-NT3 group, animals in the GFP-NT3P75 – 2 group exhibited better motor function improvements and milder neuroinflammation response.
    [Neuroscience Letters]

    Full Article

    Loss of β-Catenin Causes Cementum Hypoplasia by Hampering Cementogenic Differentiation of Axin2-Expressing Cells

    The authors evaluated the effects of β-catenin deletion in Axin2+ cells on cementogenesis. They generated triple transgenic mice to conditionally delete β-catenin in Axin2-lineage cells by crossing Axin2CreERT2/+; R26RtdTomato/+ mice with β-cateninflox/flox mice.
    [Journal Of Periodontal Research]

    Abstract
    As a scientist, how you separate the facts from the claims is just as important as how you separate your cells. See for yourself.
    REVIEWS


    nction in Rheumatoid Arthritis

    Investigators comprehensively review the deregulated miRNAs and impaired cellular functions in rheumatoid arthritis (RA) to shed light on several aspects of RA pathogenesis, with a focus on excessive inflammation, synovial hyperplasia and progressive joint damage.
    [Bone Research]

    Full Article
    INDUSTRY AND POLICY NEWS

    Stemedica Initiating Phase IIb/III Clinical Trial for Patients with Chronic Ischemic Stroke

    Stemedica Cell Technologies announced that it has initiated its Phase IIb/III, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of a single intravenous injection of allogeneic mesenchymal stem cells to subjects with ischemic stroke.
    [Stemedica Cell Technologies]

    Press Release
    FEATURED EVENT

    3D Cell Culture 2023: Models, Applications & Translation

    April 17 – 19, 2023
    Freiburg im Breisgau, Germany

    > See All Events

    JOB OPPORTUNITIES

    Assistant Professor – Stem Cells and Regenerative Medicine

    The Ottawa Hospital – Ottawa, Ontario, Canada

    Research Associate – Regenerative Therapies

    Dresden University of Technology – Dresden, Germany

    Directors of Clinical Research Programs – Cancer Biology

    IRCCS Candiolo Cancer Institute – Turin, Italy

    Postdoctoral Scholar Positions – Stem Cell-Based Therapy

    UCLA Jules Stein Eye Institute – Los Angeles, California, United States

    Adult Medical Oncologist – Sarcoma Program

    Johns Hopkins University – Baltimore, Maryland, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter